Showing results (161-170 of 245) with videos related to
Sort By:
Pageof 25
Journal of Geriatric Oncology|June 25, 2020
The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancerCamilla Lisanti, Debora Basile, Annamaria Parnofiello, et al.Journal of Cancer|July 11, 2022
Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendationsRiccardo Caccialanza, Paolo Cotogni, Emanuele Cereda, et al.British Journal of Cancer|February 13, 2019
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancerLorenzo Fornaro, Caterina Vivaldi, Annamaria Parnofiello, et al.The Oncologist|March 24, 2020
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal CancerDebora Basile, Silvio Ken Garattini, Carla Corvaja, et al.BMC Cancer|June 11, 2017
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO groupChiara Cremolini, Federica Marmorino, Fotios Loupakis, et al.Journal of Geriatric Oncology|December 16, 2018
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world studyValentina Fanotto, Lorenzo Fornaro, Roberto Bordonaro, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 22, 2025
SHORT-COURSE RADIOTHERAPY FOR OLDER PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER AND UNFIT FOR CHEMOTHERAPY: THE SOFT STUDYGerardo Rosati, Alfonso De Stefano, Angelo Restivo, et al.The Oncologist|April 16, 2022
Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving NivolumabGiulia Pasello, Martina Lorenzi, Lorenzo Calvetti, et al.International Journal of Radiation Oncology, Biology, Physics|October 29, 2025
Postoperative Single-Fraction Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer With GammaPod Technology: A Phase 2 Clinical TrialGiuseppe Facondo, Chiara Reverberi, Agnese Prisco, et al.BMC Cancer|July 24, 2020
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancerCarlotta Antoniotti, Beatrice Borelli, Daniele Rossini, et al.Pageof 25